Washington, DC Is a generic manufacturer of a name-brand drug like Prozac hamstrung by federal rules that govern the labeling of the drug originally approved by the US Food and Drug Administration (FDA)? Or does a generic manufacturer have the right and responsibility to alter the labeling of its generic drug in an effort to warn consumers and the health care community about potential adverse reactions?
April 8, 2010. By Gordon Gibb.
